Interleukin-6 Mediates G0/G1 Growth Arrest in Hepatocellular Carcinoma Through a STAT 3-Dependent Pathway

Dairmuid M. Moran, M. Adrian Mattocks, Paul A. Cahill, Leonidas G. Koniaris, Iain H. McKillop

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates diverse cell functions including proliferation and differentiation. Within the liver IL-6 signaling plays a central role during normal hepatic growth and regeneration yet can inhibit the proliferation of hepatocellular carcinoma (HCC) cells. The aim of the current study was to identify underlying mechanisms whereby IL-6 induces cell-cycle arrest in HCC cells. These studies demonstrate that IL-6 inhibits cell-cycle progression at the G0/G1 interface through inhibition of cyclin-dependent kinase (cdk) 2 and cdk4 activity in the absence of changes in total cyclin (A, D1, D3, and E) or cdk (cdk2, 4, and cdc2 p34) expression. Inhibition of signal transduction pathways associated with IL-6 receptor activation demonstrates that IL-6-dependent inhibition of G0-G1 progression occurs via Janus tyrosine kinase-signal transducers and activators of transcription-3 (Jak-STAT3)-dependent induction of p21waf1/cip1 and is independent of ERK-MAPK signaling. These data demonstrate that, while IL-6 plays a central role in hepatocyte priming and proliferation in vivo, the pronounced inhibition of proliferation observed in HCC cells occurs due to IL-6-STAT3-dependent regulation of cdk2/cdk4 activity and p21waf1/cip1 expression.

Original languageEnglish (US)
Pages (from-to)23-33
Number of pages11
JournalJournal of Surgical Research
Volume147
Issue number1
DOIs
StatePublished - Jun 1 2008

Fingerprint

Hepatocellular Carcinoma
Interleukin-6
Growth
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 2
Janus Kinases
Interleukin-6 Receptors
Cyclin A
STAT3 Transcription Factor
Liver
Cyclin D1
Cell Cycle Checkpoints
Protein-Tyrosine Kinases
Regeneration
Hepatocytes
Signal Transduction
Cell Cycle
Cytokines

Keywords

  • cyclin-dependent kinases
  • growth arrest
  • hepatocellular carcinoma
  • interleukin-6
  • mitogenesis

ASJC Scopus subject areas

  • Surgery

Cite this

Interleukin-6 Mediates G0/G1 Growth Arrest in Hepatocellular Carcinoma Through a STAT 3-Dependent Pathway. / Moran, Dairmuid M.; Mattocks, M. Adrian; Cahill, Paul A.; Koniaris, Leonidas G.; McKillop, Iain H.

In: Journal of Surgical Research, Vol. 147, No. 1, 01.06.2008, p. 23-33.

Research output: Contribution to journalArticle

Moran, Dairmuid M. ; Mattocks, M. Adrian ; Cahill, Paul A. ; Koniaris, Leonidas G. ; McKillop, Iain H. / Interleukin-6 Mediates G0/G1 Growth Arrest in Hepatocellular Carcinoma Through a STAT 3-Dependent Pathway. In: Journal of Surgical Research. 2008 ; Vol. 147, No. 1. pp. 23-33.
@article{4ac179c4ba304f4683996359db4eae7a,
title = "Interleukin-6 Mediates G0/G1 Growth Arrest in Hepatocellular Carcinoma Through a STAT 3-Dependent Pathway",
abstract = "Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates diverse cell functions including proliferation and differentiation. Within the liver IL-6 signaling plays a central role during normal hepatic growth and regeneration yet can inhibit the proliferation of hepatocellular carcinoma (HCC) cells. The aim of the current study was to identify underlying mechanisms whereby IL-6 induces cell-cycle arrest in HCC cells. These studies demonstrate that IL-6 inhibits cell-cycle progression at the G0/G1 interface through inhibition of cyclin-dependent kinase (cdk) 2 and cdk4 activity in the absence of changes in total cyclin (A, D1, D3, and E) or cdk (cdk2, 4, and cdc2 p34) expression. Inhibition of signal transduction pathways associated with IL-6 receptor activation demonstrates that IL-6-dependent inhibition of G0-G1 progression occurs via Janus tyrosine kinase-signal transducers and activators of transcription-3 (Jak-STAT3)-dependent induction of p21waf1/cip1 and is independent of ERK-MAPK signaling. These data demonstrate that, while IL-6 plays a central role in hepatocyte priming and proliferation in vivo, the pronounced inhibition of proliferation observed in HCC cells occurs due to IL-6-STAT3-dependent regulation of cdk2/cdk4 activity and p21waf1/cip1 expression.",
keywords = "cyclin-dependent kinases, growth arrest, hepatocellular carcinoma, interleukin-6, mitogenesis",
author = "Moran, {Dairmuid M.} and Mattocks, {M. Adrian} and Cahill, {Paul A.} and Koniaris, {Leonidas G.} and McKillop, {Iain H.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1016/j.jss.2007.04.022",
language = "English (US)",
volume = "147",
pages = "23--33",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Interleukin-6 Mediates G0/G1 Growth Arrest in Hepatocellular Carcinoma Through a STAT 3-Dependent Pathway

AU - Moran, Dairmuid M.

AU - Mattocks, M. Adrian

AU - Cahill, Paul A.

AU - Koniaris, Leonidas G.

AU - McKillop, Iain H.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates diverse cell functions including proliferation and differentiation. Within the liver IL-6 signaling plays a central role during normal hepatic growth and regeneration yet can inhibit the proliferation of hepatocellular carcinoma (HCC) cells. The aim of the current study was to identify underlying mechanisms whereby IL-6 induces cell-cycle arrest in HCC cells. These studies demonstrate that IL-6 inhibits cell-cycle progression at the G0/G1 interface through inhibition of cyclin-dependent kinase (cdk) 2 and cdk4 activity in the absence of changes in total cyclin (A, D1, D3, and E) or cdk (cdk2, 4, and cdc2 p34) expression. Inhibition of signal transduction pathways associated with IL-6 receptor activation demonstrates that IL-6-dependent inhibition of G0-G1 progression occurs via Janus tyrosine kinase-signal transducers and activators of transcription-3 (Jak-STAT3)-dependent induction of p21waf1/cip1 and is independent of ERK-MAPK signaling. These data demonstrate that, while IL-6 plays a central role in hepatocyte priming and proliferation in vivo, the pronounced inhibition of proliferation observed in HCC cells occurs due to IL-6-STAT3-dependent regulation of cdk2/cdk4 activity and p21waf1/cip1 expression.

AB - Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates diverse cell functions including proliferation and differentiation. Within the liver IL-6 signaling plays a central role during normal hepatic growth and regeneration yet can inhibit the proliferation of hepatocellular carcinoma (HCC) cells. The aim of the current study was to identify underlying mechanisms whereby IL-6 induces cell-cycle arrest in HCC cells. These studies demonstrate that IL-6 inhibits cell-cycle progression at the G0/G1 interface through inhibition of cyclin-dependent kinase (cdk) 2 and cdk4 activity in the absence of changes in total cyclin (A, D1, D3, and E) or cdk (cdk2, 4, and cdc2 p34) expression. Inhibition of signal transduction pathways associated with IL-6 receptor activation demonstrates that IL-6-dependent inhibition of G0-G1 progression occurs via Janus tyrosine kinase-signal transducers and activators of transcription-3 (Jak-STAT3)-dependent induction of p21waf1/cip1 and is independent of ERK-MAPK signaling. These data demonstrate that, while IL-6 plays a central role in hepatocyte priming and proliferation in vivo, the pronounced inhibition of proliferation observed in HCC cells occurs due to IL-6-STAT3-dependent regulation of cdk2/cdk4 activity and p21waf1/cip1 expression.

KW - cyclin-dependent kinases

KW - growth arrest

KW - hepatocellular carcinoma

KW - interleukin-6

KW - mitogenesis

UR - http://www.scopus.com/inward/record.url?scp=43049147317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049147317&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2007.04.022

DO - 10.1016/j.jss.2007.04.022

M3 - Article

C2 - 17574577

AN - SCOPUS:43049147317

VL - 147

SP - 23

EP - 33

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -